Single Ca2+ entry and transmitter release systems at the neuromuscular synapse.
The possibility that there exists more than one voltage-gated Ca2+ channel system subserving quantal release of neurotransmitter at nerve endings was examined by measuring the sensitivity of quantal release to agents that block Ca2+ or Ba2+ entry, namely Cd2+, Mg2+, neomycin, and bekanamycin. The results show equal effectiveness vs. release evoked by presynaptic action potentials, brief intense presynaptic depolarizations, or prolonged relatively mild depolarizations, from which it is concluded that the same channel system is involved in each case. In the presence of Ba2+ and no Ca2+, there occur essentially normal (but small) endplate potentials (epps), while in the presence of Ba2+ and Ca2+ epp amplitude and frequency of miniature epps co-modulate with stimulation frequency in a manner which corresponds to a residual Ba2+ model for augmentation. It is therefore also concluded that a single transmitter release system is responsible for normal phasic release and the asynchronous release that is mediated by Ba2+.
Guan
Y Y
YY
Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Quastel
D M
DM
Saint
D A
DA
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001464:Barium / Q000378:metabolism / Q000502:physiology; D002104:Cadmium / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism / Q000502:physiology*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D003964:Diaphragm / Q000294:innervation / Q000502:physiology; D004558:Electric Stimulation; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology; D051379:Mice; D009355:Neomycin / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D009435:Synaptic Transmission / Q000187:drug effects*
D002121:Calcium Channel Blockers; D002104:Cadmium; D001464:Barium; D009355:Neomycin; D008274:Magnesium; D002118:Calcium